RNASEH2A

Chr 19

ribonuclease H2 subunit A

Also known as: AGS4, RNASEHI, RNHIA, RNHL

The protein encoded by this gene is a component of the heterotrimeric type II ribonuclease H enzyme (RNAseH2). RNAseH2 is the major source of ribonuclease H activity in mammalian cells and endonucleolytically cleaves ribonucleotides. It is predicted to remove Okazaki fragment RNA primers during lagging strand DNA synthesis and to excise single ribonucleotides from DNA-DNA duplexes. Mutations in this gene cause Aicardi-Goutieres Syndrome (AGS), a an autosomal recessive neurological disorder characterized by progressive microcephaly and psychomotor retardation, intracranial calcifications, elevated levels of interferon-alpha and white blood cells in the cerebrospinal fluid.[provided by RefSeq, Aug 2009]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.88
Clinical SummaryRNASEH2A
🧬
Gene-Disease Validity (ClinGen)
RNASEH2A-related type 1 interferonopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 213 VUS of 565 total submissions
📖
GeneReview available — RNASEH2A
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.88LOEUF
pLI 0.004
Z-score 1.88
OE 0.45 (0.240.88)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.19Z-score
OE missense 0.96 (0.851.09)
171 obs / 178.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.45 (0.240.88)
00.351.4
Missense OE?0.96 (0.851.09)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 6 / 13.5Missense obs/exp: 171 / 178.2Syn Z: -0.59
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveRNASEH2A-related Aicardi-Goutieres syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6454th %ile
GOF
0.4578th %ile
LOF
0.3068th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

565 submitted variants in ClinVar

Classification Summary

Pathogenic20
Likely Pathogenic25
VUS213
Likely Benign254
Benign21
Conflicting17
20
Pathogenic
25
Likely Pathogenic
213
VUS
254
Likely Benign
21
Benign
17
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
16
2
1
1
20
Likely Pathogenic
16
7
1
1
25
VUS
5
186
19
3
213
Likely Benign
0
5
115
134
254
Benign
0
0
18
3
21
Conflicting
17
Total37200154142550

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 27) ClinVar copy-number / structural variants overlap RNASEH2A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

RNASEH2A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →